Lushang Health Industry Development Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 06:46 am EDT
Share
Lushang Health Industry Development Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 6,349.22 million compared to CNY 7,035.48 million a year ago. Revenue was CNY 6,349.22 million compared to CNY 7,035.48 million a year ago. Net income was CNY 503.15 million compared to CNY 412.77 million a year ago. Basic earnings per share from continuing operations was CNY 0.5 compared to CNY 0.41 a year ago. Diluted earnings per share from continuing operations was CNY 0.49 compared to CNY 0.41 a year ago.
Lushang Freda Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture and sale of pharmaceuticals and cosmetics. In terms of medicine, the Company is committed to the research and development, production and sales of Chinese patent medicines, chemical medicines, and health foods. Its products cover five fields: orthopedics, gynecology, internal medicine, ophthalmology, and pediatrics. The Company's cosmetic products involve aroma therapy, aroma skin care, aroma health care, aroma health care and other fields. In terms of raw materials, derivative products, and additives, the Company is mainly engaged in the production of hyaluronic acid raw materials.